A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
Clinical trial NCT05476900 · COMPLETED
Trial details
- NCT number
- NCT05476900
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2025-03-14
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.